Search - tctmd.com

Displaying 41 - 60 of 72

Sort: Relevancy | Date

News Conference News TCT 2019

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Michael O'Riordan

September 27, 2019

News Daily News

Earlier Care, More Data Needed to Increase Treatment Success in Tricuspid Regurgitation

Yael L. Maxwell

August 07, 2019

News Opinion Fellow Talk

Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD

Yashasvi Chugh, MD

August 05, 2019

News Conference News TVT 2019

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Shelley Wood

June 19, 2019

Presentation TVT 2019

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Presenter: Tamim Nazif

June 13, 2019

News Daily News

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

L.A. McKeown

November 02, 2018

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

Presentation TCT 2018

Early Experiences with the New TriGUARD 3 Embolic Protection Device During TAVR: The REFLECT Trial

Presenter: Tamim Nazif

September 21, 2018

News Conference News PCR London Valves 2018

MITRA-FR in the Hot Seat as Experts Debate Impact on Guidelines and Practice

Shelley Wood

September 10, 2018

News Daily News

Lotus Valve’s Return to Market in Europe Sees Further Delays

Shelley Wood

November 29, 2017

Presentation TCT 2017

Updates From the U.S. REFLECT Clinical Trial

Presenter: Tamim Nazif

October 31, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Industry News

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

August 01, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

REPRISE III: Lotus Valve Matches CoreValve in First Head-to-Head TAVR Trial

News Conference News EuroPCR 2017

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

Shelley Wood

May 16, 2017

News Conference News CRT 2017

Amid Sluggish Trial Enrollment, Transcatheter Mitral Valve Field Asks: Just How Big Is the Unmet Need?

Michael O'Riordan

February 27, 2017

News Conference News CRT 2017

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Michael O'Riordan

February 22, 2017

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

Advertisement

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Earlier Care, More Data Needed to Increase Treatment Success in Tricuspid Regurgitation

Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

High Mortality but Durable Results With Valve-in-Valve TAVR

Early Experiences with the New TriGUARD 3 Embolic Protection Device During TAVR: The REFLECT Trial

MITRA-FR in the Hot Seat as Experts Debate Impact on Guidelines and Practice

Lotus Valve’s Return to Market in Europe Sees Further Delays

Updates From the U.S. REFLECT Clinical Trial

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

Amid Sluggish Trial Enrollment, Transcatheter Mitral Valve Field Asks: Just How Big Is the Unmet Need?

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content